CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on enhancing a patented delivery system for therapeutic RNA, specifically targeting mRNA delivery for cancer treatment. The goal is to develop a safe and effective method for delivering mRNA therapeutics to cells, addressing current challenges in the field.
Sixfold Bioscience is a biotechnology company that conducts preclinical research and development on its patented Programmable Oligonucleotide Delivery System (PODS).
Proof-of-concept in vitro and in vivo data has been demonstrated for the delivery of siRNA-PODS to specific cancer cells by ligand-based targeting.
Sixfold is now looking to expand the utility of the PODS to include mRNA delivery (mRNA-PODS).
The field of mRNA therapeutics is hugely promising area of Cell and Gene therapy, where it…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
